Published Date : Apr 18, 2018
ALBANY, New York, April 18, 2018: A report by MarketResearchReports.biz titled, “United States Proton Therapy Market (Actual & Potential), Patients Treated, Reimbursement, Clinical Trails, Proton Therapy Centers, Major Deals, Key Company Profiles & Demand Forecasts to 2018 - 2025,” projects this market to witness a stellar growth in forthcoming years, owing to the rising number of cancer cases in United States, which demands greater use of proton therapy procedures.
Drastic lifestyle changes, long-term smoking and drinking habits, obesity, and pollution are some of the chief factors responsible for propelling the United States proton therapy market. A key reason for such prophesized growth is mainly due to the fact that the above-mentioned causes might lead to development of cancer, which further could be efficiently treated with the help of proton therapies. Surging funds and investments being utilized by hospitals, device manufacturers, and other parties is also significantly contributing towards the market’s growth. Increasing number of proton therapy centers, slight reduction in therapy costs, and overall technological enhancements, are few other factors triggering a highly positive potential in the market.
However, high cost needed to establish associated systems is likely to discourage small scale businesses having less capital to expand in this market, thereby restraining the United States proton therapy market. Lack of skilled workforce also is another factor notably hindering the market’s progress. As this market is still has a weak presence in various remote regions, patients from these countries often need to travel to other regions for getting treated, which is quite impossible in most cases, consequently restraining growth. Nevertheless, the market is still in its early stages and is expected to depict a lot of development on the basis of extensive research carried out by key players, thereby offsetting the restraints up to a certain degree.
For Sample Copy, click here: https://www.marketresearchreports.biz/sample/sample/1701629
Hitachi, Optivus, Varian Medical Systems, Advanced Oncotherapy plc, Ion Beam Applications (IBA), Mevion Medical Systems, and Mitsubishi Corporation., are key players operating in the United States proton therapy market. Most players are vying for designing highly efficient proton therapy systems, and are also implementing collaborations and partnerships with other companies as key strategies. Businesses operating in this market also are becoming highly patient-centric, in order improve their comfort levels as well as the operational effectiveness.
The following pointers explain key fast facts associated with the United States proton therapy market:
The United States proton therapy market is expected to cross US$7 bn in revenue by 2025.
This market will grow at a stellar CAGR of more than 15% during the forecast period from 2018 to 2025.
The proton therapy market is most lucrative in the United States as compared to other regions.
Ion Beam Applications (IBA) accounted for maximum number of proton therapy centers in United States, whereas Hitachi held the second spot.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org